title: Practitioner report involving intravenous use of vitamin K1 prompts label review and revision.
authors.affiliation: Veterinary Practitioners' Reporting Program, US Pharmacopeia, Rockville, MD 20852, USA.
authors.forename: T M
authors.initials: TM
authors.lastname: Burgess
authors.forename: E K
authors.initials: EK
authors.lastname: Meyer
authors.forename: N
authors.initials: N
authors.lastname: Bataller
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D000818:Animals; D000925:Anticoagulants / Q000506:poisoning*; D000933:Antifibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004283:Dog Diseases / Q000139:chemically induced / Q000188:drug therapy; D004285:Dogs; D004342:Drug Hypersensitivity / Q000209:etiology / Q000662:veterinary*; D004348:Drug Labeling; D006801:Humans; D007275:Injections, Intravenous / Q000662:veterinary; D011041:Poisoning / Q000188:drug therapy / Q000662:veterinary; D012378:Rodenticides / Q000506:poisoning*; D014481:United States; D014486:United States Food and Drug Administration; D010837:Vitamin K 1 / Q000008:administration & dosage / Q000009:adverse effects*; D014859:Warfarin / Q000037:antagonists & inhibitors / Q000506:poisoning
chemical_list: D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D012378:Rodenticides; D014859:Warfarin; D010837:Vitamin K 1